文献速递临床试验与 GCP基础与转化研究

右美托咪定与瑞马唑仑程序化镇静在下肢神经阻滞下糖尿病足溃疡修复术中对早期应激反应及恢复质量影响的随机对照试验方案

Effects of dexmedetomidine versus remimazolam protocolized sedation during lower limb nerve block on early stress response and quality of recovery in patients undergoing diabetic foot ulcer repair: a randomized controlled trial protocol.
PubMed 文献 · Trials · 2026-08-07

本研究为前瞻性、随机、单中心、单盲、优效性对照试验,拟纳入160例18至75岁择期行糖尿病足溃疡修复术的患者,随机分为右美托咪定组(A组)与瑞马唑仑组(B组)。主要结局为血清皮质醇从术前基线至术后2小时的变化,次要结局包括生命体征、术后疼痛评分、术中应激水平、术后恢复质量及患者与术者满意度。

要点

  • 下肢神经阻滞为糖尿病足溃疡修复术首选麻醉,但常需辅助程序化镇静镇痛。
  • 右美托咪定与瑞马唑仑对早期应激反应及恢复质量的比较尚不明确。
  • 主要结局为血清皮质醇从术前基线至术后2小时的变化。

核心结论

  • 本试验旨在比较右美托咪定与瑞马唑仑程序化镇静对糖尿病足溃疡修复术患者应激激素释放及早期恢复质量的影响。

研究设计与样本

  • 前瞻性、随机、单中心、单盲、优效性对照试验,拟纳入160例18至75岁择期行糖尿病足溃疡修复术的患者,随机分为右美托咪定组(A组)与瑞马唑仑组(B组)。

关键数值与推荐

  • 主要结局为血清皮质醇从术前基线至术后2小时的变化。
  • 次要结局包括生命体征、术后疼痛强度评分、术中应激水平、术后恢复质量及患者与术者满意度评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For patients undergoing diabetic foot ulcer (DFU) repair, lower limb nerve block is the preferred anesthetic regimen. However, the block alone often fails to fully eliminate intraoperative anxiety and stress responses. Adjunctive procedural sedation and analgesia (PSA), using agents such as dexmedetomidine or remimazolam, is a key strategy to enhance surgical comfort. Nevertheless, the comparative effects of these two agents on early stress response and quality of recovery remain unclear. METHODS: This is a prospective, randomized, single-center, single-blind, superiority controlled trial. A total of 160 patients aged 18 to 75 years undergoing elective DFU repair will be enrolled and randomized into Group A (dexmedetomidine) and Group B (remimazolam). The primary outcome is the change in serum cortisol levels from preoperative baseline to 2 h postoperatively. Secondary outcomes include the following: vital signs; postoperative pain intensity scores; intraoperative stress level; postoperative quality of recovery; and patient and surgeon satisfaction scores. DISCUSSION: This study aims to compare the effects of dexmedetomidine and remimazolam PSA on attenuating stress hormone release and improving early postoperative quality of recovery in patients undergoing DFU repair. The future findings will provide high-quality clinical evidence for reducing perioperative stress levels, enhancing patient comfort, and accelerating postoperative recovery. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2500113746. Registered on 2 December 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Tang Y, Hou J, Wu S, et al. Effects of dexmedetomidine versus remimazolam protocolized sedation during lower limb nerve block on early stress response and quality of recovery in patients undergoing diabetic foot ulcer repair: a randomized controlled trial protocol. Trials. 2026. PMID: 42855698. doi:10.1186/s13063-026-09937-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。